The association of relative telomere length with symptomatic peripheral arterial disease: Results from the CAVASIC study

Atherosclerosis

Volumn 229, Issue 2, 2013, Pages 469-474

  Raschenberger, Julia ^a   Kollerits, Barbara ^a   Hammerer Lercher, Angelika ^b   Rantner, Barbara ^a   Stadler, Marietta ^c   Haun, Margot ^a   Klein Weigel, Peter ^d   Fraedrich, Gustav ^a   Kronenberg, Florian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c HIETZING HOSPITAL   (Austria)

^d HELIOS KLINIKUM BERLIN BUCH   (Germany)

Author keywords

Aging; Atherosclerosis; Cardiovascular disease; Chromosomal stability; Peripheral arterial disease; Telomere length

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RISK FACTOR; SMOKING; TELOMERE SHORTENING;

AGING; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHROMOSOMAL STABILITY; PERIPHERAL ARTERIAL DISEASE; TELOMERE LENGTH;

ADULT; AGED; AGING; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC MARKERS; HUMANS; INTERMITTENT CLAUDICATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; TELOMERE;

EID: 84880436716     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.05.027     Document Type: Article

References (56)

1. Weitz J.I., Byrne J., Clagett G.P., et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996, 94:3026-3049.
2. Kollerits B., Heinrich J., Pichler M., et al. Intermittent claudication in the Erfurt Male Cohort (ERFORT) Study: its determinants and the impact on mortality. Apopulation-based prospective cohort study with 30 years of follow-up. Atherosclerosis 2008, 198:214-222.
3. Lamina C., Meisinger C., Heid I.M., et al. Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up. Eur Heart J 2006, 27:2580-2587.
4. Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743.
5. Mukherjee D., Cho L. Peripheral arterial disease: considerations in risks, diagnosis, and treatment. JNatl Med Assoc 2009, 101:999-1008.
6. Moyzis R.K., Buckingham J.M., Cram L.S., et al. Ahighly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 1988, 85:6622-6626.
7. Blackburn E.H., Greider C.W., Szostak J.W. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006, 12:1133-1138.
8. Baird D.M. Telomere dynamics in human cells. Biochimie 2008, 90:116-121.
9. Von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002, 27:339-344.
10. Kurz D.J., Decary S., Hong Y., et al. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. JCell Sci 2004, 117:2417-2426.
11. Aviv A., Valdes A.M., Spector T.D. Human telomere biology: pitfalls of moving from the laboratory to epidemiology. Int J Epidemiol 2006, 35:1424-1429.
12. Masi S., Nightingale C.M., Day I.N., et al. Inflammation and not cardiovascular risk factors is associated with short leukocyte telomere length in 13- to 16-year-old adolescents. Arterioscler Thromb Vasc Biol 2012, 32:2034.
13. Cesare A.J., Reddel R.R. Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 2010, 11:319-330.
14. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585-621.
15. d'Adda di F.F., Reaper P.M., Clay-Farrace L., et al. ADNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
16. Zhou X.J., Saxena R., Liu Z., Vaziri N.D., Silva F.G. Renal senescence in 2008: progress and challenges. Int Urol Nephrol 2008, 40:823-839.
17. Okuda K., Bardeguez A., Gardner J.P., et al. Telomere length in the newborn. Pediatr Res 2002, 52:377-381.
18. Frenck R.W., Blackburn E.H., Shannon K.M. The rate of telomere sequence lossin human leukocytes varies with age. Proc Natl Acad Sci U S A 1998, 95:5607-5610.
19. Zeichner S.L., Palumbo P., Feng Y., et al. Rapid telomere shortening in children. Blood 1999, 93:2824-2830.
20. Rufer N., Brummendorf T.H., Kolvraa S., et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. JExp Med 1999, 190:157-167.
21. Willeit P., Willeit J., Brandstätter A., et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol 2010, 30:1649-1656.
22. Werner N., Nickenig G. Endothelial progenitor cells in health and atherosclerotic disease. Ann Med 2007, 39:82-90.
23. Fadini G.P., Agostini C., Sartore S., Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007, 194:46-54.
24. Ross R. Atherosclerosis-an inflammatory disease. NEngl J Med 1999, 340:115-126.
25. Münzel T., Gori T., Bruno R.M., Taddei S. Is oxidative stress a therapeutic target in cardiovascular disease?. Eur Heart J 2010, 31:2741-2748.
26. Oikawa S., Kawanishi S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 1999, 453:365-368.
27. Houben J.M., Moonen H.J., van Schooten F.J., Hageman G.J. Telomere length assessment: biomarker of chronic oxidative stress?. Free Radic Biol Med 2008, 44:235-246.
28. Brouilette S.W., Moore J.S., McMahon A.D., et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland primary prevention study: a nested case-control study. Lancet 2007, 369:107-114.
29. Samani N.J., van der Harst P. Biological ageing and cardiovascular disease. Heart 2008, 94:537-539.
30. Willeit P., Willeit J., Mayr A., et al. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010, 304:69-75.
31. Ma H., Zhou Z., Wei S., et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One 2011, 6:e20466.
32. Rantner B., Kollerits B., Anderwald-Stadler M., et al. Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study. Clin Chem 2008, 54:851-857.
33. Kollerits B., Sturm G., Lamina C., et al. Comparison and evaluation of cardiac biomarkers in patients with intermittent claudication: results from the CAVASIC study. Clin Chem 2013, 59:692-702.
34. Rose G.A. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962, 27:645-658.
35. Levey A.S., Stevens L.A., Schmid C.H., et al. Anew equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
36. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002, 30:e47.
37. Ehrlenbach S., Willeit P., Kiechl S., et al. Influences on the reduction of relative telomere length over 10 years in the population-based Bruneck Study: introduction of a well-controlled high-throughput assay. Int J Epidemiol 2009, 38:1725-1734.
38. Codd V., Nelson C.P., Albrecht E., et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet 2013, 45:422.
39. Minamino T., Miyauchi H., Yoshida T., et al. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002, 105:1541-1544.
40. Aviv A. Genetics of leukocyte telomere length and its role in atherosclerosis. Mutat Res 2012, 730:68-74.
41. Buerrig K.F. The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb Vasc Biol 1991, 11:1678-1689.
42. Ross R., Wight T.N., Strandness E., Thiele B. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 1984, 114:79-93.
43. Broccoli D., Young J.W., de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci U S A 1995, 92:9082-9086.
44. Morrison S.J., Prowse K.R., Ho P., Weissman I.L. Telomerase activity in hematopoieticcells is associated with self-renewal potential. Immunity 1996, 5:207-216.
45. Vaziri H., Dragowska W., Allsopp R.C., et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994, 91:9857-9860.
46. Dei Cas A., Spigoni V., Franzini L., et al. Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy young adults. Nutr Metab Cardiovasc Dis 2013, 23:272-278.
47. Chen W., Gardner J.P., Kimura M., et al. Leukocyte telomere length is associated with HDL cholesterol levels: the Bogalusa heart study. Atherosclerosis 2009, 205:620-625.
48. Ansell B.J. Targeting the anti-inflammatory effects of high-density lipoprotein. Am J Cardiol 2007, 100:n3-n9.
49. Norata G.D., Catapano A.L. Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag 2005, 1:119-129.
50. Negre-Salvayre A., Dousset N., Ferretti G., et al. Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Radic Biol Med 2006, 41:1031-1040.
51. Brouilette S., Singh R.K., Thompson J.R., Goodall A.H., Samani N.J. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2003, 23:842-846.
52. Farzaneh-Far R., Cawthon R.M., Na B., et al. Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol 2008, 28:1379-1384.
53. Butt H.Z., Atturu G., London N.J., Sayers R.D., Bown M.J. Telomere length dynamics in vascular disease: a review. Eur J Vasc Endovasc Surg 2010, 40:17-26.
54. Zhang W., Chen Y., Yang X., et al. Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease. PLoS One 2012, 7:e47029.
55. Blackburn E.H. Structure and function of telomeres. Nature 1991, 350:569-573.
56. Müller T., Dieplinger B., Poelz W., et al. Amino-terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease Study. Clin Chem 2009, 55:68-77.